Translational Metabolism Unit, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
J Nutr. 2021 Dec 3;151(12):3606-3616. doi: 10.1093/jn/nxab309.
Cellular increases in oxidative stress (OxS) and decline in mitochondrial function are identified as key defects in aging, but underlying mechanisms are poorly understood and interventions are lacking. Defects linked to OxS and impaired mitochondrial fuel oxidation, such as inflammation, insulin resistance, endothelial dysfunction, and aging hallmarks, are present in older humans and are associated with declining strength and cognition, as well as the development of sarcopenic obesity. Investigations on the origins of elevated OxS and mitochondrial dysfunction in older humans led to the discovery that deficiencies of the antioxidant tripeptide glutathione (GSH) and its precursor amino acids glycine and cysteine may be contributory. Supplementation with GlyNAC (combination of glycine and N-acetylcysteine as a cysteine precursor) was found to improve/correct cellular glycine, cysteine, and GSH deficiencies; lower OxS; and improve mitochondrial function, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, and multiple aging hallmarks; and improve muscle strength, exercise capacity, cognition, and body composition. This review discusses evidence from published rodent studies and human clinical trials to provide a detailed summary of available knowledge regarding the effects of GlyNAC supplementation on age-associated defects and aging hallmarks, as well as discussing why GlyNAC supplementation could be effective in promoting healthy aging. It is particularly exciting that GlyNAC supplementation appears to reverse multiple aging hallmarks, and if confirmed in a randomized clinical trial, it could introduce a transformative paradigm shift in aging and geriatrics. GlyNAC supplementation could be a novel nutritional approach to improve age-associated defects and promote healthy aging, and existing data strongly support the need for additional studies to explore the role and impact of GlyNAC supplementation in aging.
细胞氧化应激(OxS)增加和线粒体功能下降被认为是衰老的关键缺陷,但潜在机制尚不清楚,也缺乏干预措施。与 OxS 和受损的线粒体燃料氧化相关的缺陷,如炎症、胰岛素抵抗、内皮功能障碍和衰老特征,在老年人中存在,并与力量和认知能力下降以及肌少症性肥胖的发展有关。对老年人 OxS 和线粒体功能障碍起源的研究导致发现,抗氧化三肽谷胱甘肽(GSH)及其前体氨基酸甘氨酸和半胱氨酸的缺乏可能是促成因素。补充 GlyNAC(甘氨酸和 N-乙酰半胱氨酸的组合,作为半胱氨酸前体)被发现可改善/纠正细胞甘氨酸、半胱氨酸和 GSH 缺乏;降低 OxS;并改善线粒体功能、炎症、胰岛素抵抗、内皮功能障碍、遗传毒性和多种衰老特征;并改善肌肉力量、运动能力、认知能力和身体成分。这篇综述讨论了已发表的啮齿动物研究和人体临床试验的证据,详细总结了关于 GlyNAC 补充对与年龄相关的缺陷和衰老特征的影响的现有知识,同时还讨论了为什么 GlyNAC 补充可能有效促进健康衰老。特别令人兴奋的是,GlyNAC 补充似乎可以逆转多种衰老特征,如果在随机临床试验中得到证实,它可能会在衰老和老年医学领域带来变革性的范式转变。GlyNAC 补充可能是一种改善与年龄相关缺陷和促进健康衰老的新的营养方法,现有数据强烈支持需要进一步研究探索 GlyNAC 补充在衰老中的作用和影响。